世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ディスレクシア治療の世界市場成長(現状と展望)2024-2030年


Global Dyslexia Treatment Market Growth (Status and Outlook) 2024-2030

LPI(LPインフォメーション)の最新調査によると、失読症治療の世界市場規模は2023年に100万米ドルと評価されました。下流市場での需要の増加に伴い、難読症治療薬は2030年までに再調整された規模になると予測さ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2024年12月3日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
108 英語

 

サマリー

LPI(LPインフォメーション)の最新調査によると、失読症治療の世界市場規模は2023年に100万米ドルと評価されました。下流市場での需要の増加に伴い、難読症治療薬は2030年までに再調整された規模になると予測され、レビュー期間中のCAGRは%である。
この調査レポートは、世界の難読症治療市場の成長可能性を明らかにしています。難読症治療は今後の市場において安定した成長を示すと予測される。しかし、製品の差別化、コストの削減、サプライチェーンの最適化は、ディスレクシア治療薬の普及に不可欠であることに変わりはありません。市場参加者は、研究開発への投資、戦略的パートナーシップの構築、進化する消費者の嗜好に合わせた製品の提供など、難読症治療市場がもたらす大きなチャンスを活かす必要がある。
難読症は神経学的な基盤があり、多くの場合遺伝性である。読み、書き、綴り、構成に困難を伴う。機能的磁気共鳴画像法は、ディスレクシア患者の脳の発達と機能が異なることを示している3。ディスレクシアは流暢な読書を困難にし、学業上の成功だけでなく、自尊心や社会的情緒の発達にも影響を及ぼす。ディスレクシアが若年成人に及ぼす長期的な影響としては、学業不振、うつ病、自殺・非行・再犯のリスクの増加などがある。実際、調査によると、刑務所に収容されている非識字者のうち、ディスレクシアの割合が高い。
世界の医薬品市場は、2022年には1,475億ドルに達し、今後6年間の年平均成長率は5%である。医薬品市場には、化学医薬品と生物学的製剤が含まれる。生物製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要とする患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の大流行はワクチン開発とサプライチェーン管理の重要性を浮き彫りにし、製薬企業が公衆衛生の新たなニーズに機敏に対応する必要性をさらに強調している。
主な特徴
失読症治療市場に関する本レポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。
市場規模と成長:この調査レポートは、失読症治療市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分(薬物治療、運動治療など)、地域別内訳を含む場合があります。
市場の促進要因と課題:政府規制、環境問題、技術の進歩、消費者の嗜好の変化など、難読症治療市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、高額な初期費用など、業界が直面する課題も浮き彫りにすることができます。
競合情勢:この調査レポートは、失読症治療市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれます。また、新興プレーヤーとその潜在的な市場への影響も強調することができます。
技術開発:この調査レポートは、失読症治療産業における最新の技術開発を掘り下げることができます。これには、失読症治療技術の進歩、失読症治療の新規参入、失読症治療の新規投資、失読症治療の将来を形作るその他の技術革新が含まれます。
川下の事業者の好み:このレポートは、ディスレクシア治療市場における顧客の購買行動や採用動向を明らかにします。このレポートには、顧客の購買意思決定やディスレクシア治療製品の嗜好に影響を与える要因が含まれています。
政府の政策とインセンティブ:この調査レポートは、政府の政策やインセンティブが失読症治療市場に与える影響を分析しています。これには、ディスレクシア治療市場の促進を目的とした規制枠組み、補助金、税制優遇措置などの評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。
環境への影響と持続可能性当調査レポートでは、失読症治療市場の環境への影響と持続可能性の側面を評価します。
市場予測と将来展望:調査レポートでは、実施した分析に基づいて、失読症治療産業の市場予測と展望を提供しています。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。
提言と機会本レポートでは最後に、業界関係者、政策立案者、投資家への提言を掲載しています。市場関係者が新たなトレンドを活用し、課題を克服し、失読症治療市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場の細分化
失読症治療市場はタイプ別と用途別に分類されます。2019-2030年の期間について、セグメント間の成長により、タイプ別、アプリケーション別の消費額の正確な計算と予測を提供します。
タイプ別セグメント
薬物治療
運動療法
その他
用途別セグメント
病院薬局
小売薬局
オンライン薬局
本レポートは地域別にも市場を分割しています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
DKファーマケム
ファイザー
RPGグループ
ウォレス・ファーマシューティカルズ
シアンヘルスケア
ローデス・ファーマシューティカルズ
パデュー・ファーマ
シャームコ
ユニザー・ファーマシューティカルズ
コグニフィット


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dyslexia Treatment Market Size 2019-2030
2.1.2 Dyslexia Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Dyslexia Treatment Segment by Type
2.2.1 Drug Treatment
2.2.2 Exercise Treatment
2.2.3 Others
2.3 Dyslexia Treatment Market Size by Type
2.3.1 Dyslexia Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Dyslexia Treatment Market Size Market Share by Type (2019-2024)
2.4 Dyslexia Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Dyslexia Treatment Market Size by Application
2.5.1 Dyslexia Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Dyslexia Treatment Market Size Market Share by Application (2019-2024)
3 Dyslexia Treatment Market Size by Player
3.1 Dyslexia Treatment Market Size Market Share by Players
3.1.1 Global Dyslexia Treatment Revenue by Players (2019-2024)
3.1.2 Global Dyslexia Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Dyslexia Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Dyslexia Treatment by Regions
4.1 Dyslexia Treatment Market Size by Regions (2019-2024)
4.2 Americas Dyslexia Treatment Market Size Growth (2019-2024)
4.3 APAC Dyslexia Treatment Market Size Growth (2019-2024)
4.4 Europe Dyslexia Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Dyslexia Treatment Market Size Growth (2019-2024)
5 Americas
5.1 Americas Dyslexia Treatment Market Size by Country (2019-2024)
5.2 Americas Dyslexia Treatment Market Size by Type (2019-2024)
5.3 Americas Dyslexia Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dyslexia Treatment Market Size by Region (2019-2024)
6.2 APAC Dyslexia Treatment Market Size by Type (2019-2024)
6.3 APAC Dyslexia Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Dyslexia Treatment by Country (2019-2024)
7.2 Europe Dyslexia Treatment Market Size by Type (2019-2024)
7.3 Europe Dyslexia Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dyslexia Treatment by Region (2019-2024)
8.2 Middle East & Africa Dyslexia Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Dyslexia Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Dyslexia Treatment Market Forecast
10.1 Global Dyslexia Treatment Forecast by Regions (2025-2030)
10.1.1 Global Dyslexia Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Dyslexia Treatment Forecast
10.1.3 APAC Dyslexia Treatment Forecast
10.1.4 Europe Dyslexia Treatment Forecast
10.1.5 Middle East & Africa Dyslexia Treatment Forecast
10.2 Americas Dyslexia Treatment Forecast by Country (2025-2030)
10.2.1 United States Dyslexia Treatment Market Forecast
10.2.2 Canada Dyslexia Treatment Market Forecast
10.2.3 Mexico Dyslexia Treatment Market Forecast
10.2.4 Brazil Dyslexia Treatment Market Forecast
10.3 APAC Dyslexia Treatment Forecast by Region (2025-2030)
10.3.1 China Dyslexia Treatment Market Forecast
10.3.2 Japan Dyslexia Treatment Market Forecast
10.3.3 Korea Dyslexia Treatment Market Forecast
10.3.4 Southeast Asia Dyslexia Treatment Market Forecast
10.3.5 India Dyslexia Treatment Market Forecast
10.3.6 Australia Dyslexia Treatment Market Forecast
10.4 Europe Dyslexia Treatment Forecast by Country (2025-2030)
10.4.1 Germany Dyslexia Treatment Market Forecast
10.4.2 France Dyslexia Treatment Market Forecast
10.4.3 UK Dyslexia Treatment Market Forecast
10.4.4 Italy Dyslexia Treatment Market Forecast
10.4.5 Russia Dyslexia Treatment Market Forecast
10.5 Middle East & Africa Dyslexia Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Dyslexia Treatment Market Forecast
10.5.2 South Africa Dyslexia Treatment Market Forecast
10.5.3 Israel Dyslexia Treatment Market Forecast
10.5.4 Turkey Dyslexia Treatment Market Forecast
10.5.5 GCC Countries Dyslexia Treatment Market Forecast
10.6 Global Dyslexia Treatment Forecast by Type (2025-2030)
10.7 Global Dyslexia Treatment Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 DK Pharmachem
11.1.1 DK Pharmachem Company Information
11.1.2 DK Pharmachem Dyslexia Treatment Product Offered
11.1.3 DK Pharmachem Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 DK Pharmachem Main Business Overview
11.1.5 DK Pharmachem Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Dyslexia Treatment Product Offered
11.2.3 Pfizer Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 RPG Group
11.3.1 RPG Group Company Information
11.3.2 RPG Group Dyslexia Treatment Product Offered
11.3.3 RPG Group Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 RPG Group Main Business Overview
11.3.5 RPG Group Latest Developments
11.4 Wallace Pharmaceuticals
11.4.1 Wallace Pharmaceuticals Company Information
11.4.2 Wallace Pharmaceuticals Dyslexia Treatment Product Offered
11.4.3 Wallace Pharmaceuticals Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Wallace Pharmaceuticals Main Business Overview
11.4.5 Wallace Pharmaceuticals Latest Developments
11.5 Cian Healthcare
11.5.1 Cian Healthcare Company Information
11.5.2 Cian Healthcare Dyslexia Treatment Product Offered
11.5.3 Cian Healthcare Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cian Healthcare Main Business Overview
11.5.5 Cian Healthcare Latest Developments
11.6 Rhodes Pharmaceuticals
11.6.1 Rhodes Pharmaceuticals Company Information
11.6.2 Rhodes Pharmaceuticals Dyslexia Treatment Product Offered
11.6.3 Rhodes Pharmaceuticals Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Rhodes Pharmaceuticals Main Business Overview
11.6.5 Rhodes Pharmaceuticals Latest Developments
11.7 Purdue Pharma
11.7.1 Purdue Pharma Company Information
11.7.2 Purdue Pharma Dyslexia Treatment Product Offered
11.7.3 Purdue Pharma Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Purdue Pharma Main Business Overview
11.7.5 Purdue Pharma Latest Developments
11.8 Shermco
11.8.1 Shermco Company Information
11.8.2 Shermco Dyslexia Treatment Product Offered
11.8.3 Shermco Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Shermco Main Business Overview
11.8.5 Shermco Latest Developments
11.9 Unither Pharmaceuticals
11.9.1 Unither Pharmaceuticals Company Information
11.9.2 Unither Pharmaceuticals Dyslexia Treatment Product Offered
11.9.3 Unither Pharmaceuticals Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Unither Pharmaceuticals Main Business Overview
11.9.5 Unither Pharmaceuticals Latest Developments
11.10 CogniFit
11.10.1 CogniFit Company Information
11.10.2 CogniFit Dyslexia Treatment Product Offered
11.10.3 CogniFit Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 CogniFit Main Business Overview
11.10.5 CogniFit Latest Developments
12 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

According to our LPI (LP Information) latest study, the global Dyslexia Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Dyslexia Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Dyslexia Treatment market. Dyslexia Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Dyslexia Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Dyslexia Treatment market.
Dyslexia is neurologically based and often hereditary. It is associated with difficulties in reading, writing, spelling and organization. Functional Magnetic Resonance Imaging shows that the brains of people with dyslexia develop and function in a different way.3 Dyslexia makes fluent reading difficult, which affects not only academic success but also self-esteem and social-emotional development. The long-term effects of dyslexia on young adults include school failure, depression and increased risk of suicide, delinquency and reoffending. Indeed, surveys show that amongst the high percentage of illiterate people in prison, a disproportionate number have dyslexia.The systems.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Dyslexia Treatment market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Dyslexia Treatment market. It may include historical data, market segmentation by Type (e.g., Drug Treatment, Exercise Treatment), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Dyslexia Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Dyslexia Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Dyslexia Treatment industry. This include advancements in Dyslexia Treatment technology, Dyslexia Treatment new entrants, Dyslexia Treatment new investment, and other innovations that are shaping the future of Dyslexia Treatment.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Dyslexia Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Dyslexia Treatment product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Dyslexia Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Dyslexia Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Dyslexia Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Dyslexia Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Dyslexia Treatment market.
Market Segmentation:
Dyslexia Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Drug Treatment
Exercise Treatment
Others
Segmentation by application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
DK Pharmachem
Pfizer
RPG Group
Wallace Pharmaceuticals
Cian Healthcare
Rhodes Pharmaceuticals
Purdue Pharma
Shermco
Unither Pharmaceuticals
CogniFit



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dyslexia Treatment Market Size 2019-2030
2.1.2 Dyslexia Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Dyslexia Treatment Segment by Type
2.2.1 Drug Treatment
2.2.2 Exercise Treatment
2.2.3 Others
2.3 Dyslexia Treatment Market Size by Type
2.3.1 Dyslexia Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Dyslexia Treatment Market Size Market Share by Type (2019-2024)
2.4 Dyslexia Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Dyslexia Treatment Market Size by Application
2.5.1 Dyslexia Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Dyslexia Treatment Market Size Market Share by Application (2019-2024)
3 Dyslexia Treatment Market Size by Player
3.1 Dyslexia Treatment Market Size Market Share by Players
3.1.1 Global Dyslexia Treatment Revenue by Players (2019-2024)
3.1.2 Global Dyslexia Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Dyslexia Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Dyslexia Treatment by Regions
4.1 Dyslexia Treatment Market Size by Regions (2019-2024)
4.2 Americas Dyslexia Treatment Market Size Growth (2019-2024)
4.3 APAC Dyslexia Treatment Market Size Growth (2019-2024)
4.4 Europe Dyslexia Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Dyslexia Treatment Market Size Growth (2019-2024)
5 Americas
5.1 Americas Dyslexia Treatment Market Size by Country (2019-2024)
5.2 Americas Dyslexia Treatment Market Size by Type (2019-2024)
5.3 Americas Dyslexia Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dyslexia Treatment Market Size by Region (2019-2024)
6.2 APAC Dyslexia Treatment Market Size by Type (2019-2024)
6.3 APAC Dyslexia Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Dyslexia Treatment by Country (2019-2024)
7.2 Europe Dyslexia Treatment Market Size by Type (2019-2024)
7.3 Europe Dyslexia Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dyslexia Treatment by Region (2019-2024)
8.2 Middle East & Africa Dyslexia Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Dyslexia Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Dyslexia Treatment Market Forecast
10.1 Global Dyslexia Treatment Forecast by Regions (2025-2030)
10.1.1 Global Dyslexia Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Dyslexia Treatment Forecast
10.1.3 APAC Dyslexia Treatment Forecast
10.1.4 Europe Dyslexia Treatment Forecast
10.1.5 Middle East & Africa Dyslexia Treatment Forecast
10.2 Americas Dyslexia Treatment Forecast by Country (2025-2030)
10.2.1 United States Dyslexia Treatment Market Forecast
10.2.2 Canada Dyslexia Treatment Market Forecast
10.2.3 Mexico Dyslexia Treatment Market Forecast
10.2.4 Brazil Dyslexia Treatment Market Forecast
10.3 APAC Dyslexia Treatment Forecast by Region (2025-2030)
10.3.1 China Dyslexia Treatment Market Forecast
10.3.2 Japan Dyslexia Treatment Market Forecast
10.3.3 Korea Dyslexia Treatment Market Forecast
10.3.4 Southeast Asia Dyslexia Treatment Market Forecast
10.3.5 India Dyslexia Treatment Market Forecast
10.3.6 Australia Dyslexia Treatment Market Forecast
10.4 Europe Dyslexia Treatment Forecast by Country (2025-2030)
10.4.1 Germany Dyslexia Treatment Market Forecast
10.4.2 France Dyslexia Treatment Market Forecast
10.4.3 UK Dyslexia Treatment Market Forecast
10.4.4 Italy Dyslexia Treatment Market Forecast
10.4.5 Russia Dyslexia Treatment Market Forecast
10.5 Middle East & Africa Dyslexia Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Dyslexia Treatment Market Forecast
10.5.2 South Africa Dyslexia Treatment Market Forecast
10.5.3 Israel Dyslexia Treatment Market Forecast
10.5.4 Turkey Dyslexia Treatment Market Forecast
10.5.5 GCC Countries Dyslexia Treatment Market Forecast
10.6 Global Dyslexia Treatment Forecast by Type (2025-2030)
10.7 Global Dyslexia Treatment Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 DK Pharmachem
11.1.1 DK Pharmachem Company Information
11.1.2 DK Pharmachem Dyslexia Treatment Product Offered
11.1.3 DK Pharmachem Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 DK Pharmachem Main Business Overview
11.1.5 DK Pharmachem Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Dyslexia Treatment Product Offered
11.2.3 Pfizer Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 RPG Group
11.3.1 RPG Group Company Information
11.3.2 RPG Group Dyslexia Treatment Product Offered
11.3.3 RPG Group Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 RPG Group Main Business Overview
11.3.5 RPG Group Latest Developments
11.4 Wallace Pharmaceuticals
11.4.1 Wallace Pharmaceuticals Company Information
11.4.2 Wallace Pharmaceuticals Dyslexia Treatment Product Offered
11.4.3 Wallace Pharmaceuticals Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Wallace Pharmaceuticals Main Business Overview
11.4.5 Wallace Pharmaceuticals Latest Developments
11.5 Cian Healthcare
11.5.1 Cian Healthcare Company Information
11.5.2 Cian Healthcare Dyslexia Treatment Product Offered
11.5.3 Cian Healthcare Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cian Healthcare Main Business Overview
11.5.5 Cian Healthcare Latest Developments
11.6 Rhodes Pharmaceuticals
11.6.1 Rhodes Pharmaceuticals Company Information
11.6.2 Rhodes Pharmaceuticals Dyslexia Treatment Product Offered
11.6.3 Rhodes Pharmaceuticals Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Rhodes Pharmaceuticals Main Business Overview
11.6.5 Rhodes Pharmaceuticals Latest Developments
11.7 Purdue Pharma
11.7.1 Purdue Pharma Company Information
11.7.2 Purdue Pharma Dyslexia Treatment Product Offered
11.7.3 Purdue Pharma Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Purdue Pharma Main Business Overview
11.7.5 Purdue Pharma Latest Developments
11.8 Shermco
11.8.1 Shermco Company Information
11.8.2 Shermco Dyslexia Treatment Product Offered
11.8.3 Shermco Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Shermco Main Business Overview
11.8.5 Shermco Latest Developments
11.9 Unither Pharmaceuticals
11.9.1 Unither Pharmaceuticals Company Information
11.9.2 Unither Pharmaceuticals Dyslexia Treatment Product Offered
11.9.3 Unither Pharmaceuticals Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Unither Pharmaceuticals Main Business Overview
11.9.5 Unither Pharmaceuticals Latest Developments
11.10 CogniFit
11.10.1 CogniFit Company Information
11.10.2 CogniFit Dyslexia Treatment Product Offered
11.10.3 CogniFit Dyslexia Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 CogniFit Main Business Overview
11.10.5 CogniFit Latest Developments
12 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/12 10:26

153.40 円

161.58 円

198.54 円

ページTOPに戻る